menu
    • menu

    Company profile for ECI Pharmaceuticals LLC

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ECI Pharmaceuticals is a privately owned US generic drug manufacturer. ECI Pharma carries out pharmaceutical research and development, as well as the marketing and distribution of a wide range of generic prescription drugs across multiple therapeutic categories and dosage forms. ECI Pharma has FDA-approved abbreviated new drug applications (ANDAs) and has several products in its pipeline with ANDA and NDA approvals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ECI Pharmaceuticals LLCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5311 NW 35th Terrace Ft. Lauderdale, FL 33309
    Telephone
    Telephone
    (954) 486-8181
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ecipharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eci-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ECI Pharmaceuticals Receives FDA Warning Letter
    ECI Pharmaceuticals Receives FDA Warning Letter

    23 Mar 2022

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eci-pharmaceuticals-llc-625254-02032022-0

    FDA
    23 Mar 2022
    Share Share
    ECI Pharmaceuticals, LLC Receives FDA Warning Letter
    ECI Pharmaceuticals, LLC Receives FDA Warning Letter

    16 Feb 2022

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eci-pharmaceuticals-llc-625254-02032022

    FDA
    16 Feb 2022
    Share Share
    ECI Pharma Signs Agreement to Be Exclusive U.S. Distributor of Generic Cialis®
    ECI Pharma Signs Agreement to Be Exclusive U.S. Distributor of Generic Cialis®

    10 May 2021

    // PRESS RELEASE

    https://ecipharma.com/2021/05/10/eci-pharmaceuticals-llc-signs-agreement-to-be-exclusive-u-s-distributor-of-generic-cialis/

    PRESS RELEASE
    10 May 2021
    Share Share
    ECI PharmaEnters into Exclusive U.S. Distribution Agreement for Ibuprofen
    ECI PharmaEnters into Exclusive U.S. Distribution Agreement for Ibuprofen

    23 Apr 2021

    // PRESS RELEASE

    https://ecipharma.com/2021/04/23/eci-pharmaceuticals-llc-enters-into-exclusive-u-s-distribution-agreement-for-ibuprofen/

    PRESS RELEASE
    23 Apr 2021
    Share Share
    ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen
    ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen

    23 Apr 2021

    // PRESS RELEASE

    https://ecipharma.com/2021/04/23/eci-pharmaceuticals-llc-enters-into-exclusive-u-s-distribution-agreement-for-ibuprofen/

    PRESS RELEASE
    23 Apr 2021
    Share Share
    ECI Pharm`s Generic Chlordiazepoxide; Clidinium bromide Receives Approval in US
    ECI Pharm`s Generic Chlordiazepoxide; Clidinium bromide Receives Approval in US

    24 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213530

    FDA
    24 Oct 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search